[(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro-2-(methylthio)-6-[(1,3-thiazol-2-ylmethyl)amino]-4-pyrimidinyl}hydrazino)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide → [(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro-2-(methylthio)-6-[(1,3-thiazol-2-ylmethyl)amino]-4-pyrimidinyl}hydrazino)-3-oxopropyl]hydroxyformamide
反応式
[CH:1]1([CH2:6][C@@H:7]([C:19]([NH:21][NH:22][C:23]2[C:28]([F:29])=[C:27]([NH:30][CH2:31][C:32]3[S:33][CH:34]=[CH:35][N:36]=3)[N:26]=[C:25]([S:37][CH3:38])[N:24]=2)=[O:20])[CH2:8][N:9]([O:12]C2CCCCO2)[CH:10]=[O:11])[CH2:5][CH2:4][CH2:3][CH2:2]1>C(O)(=O)C.O>[CH:1]1([CH2:6][C@@H:7]([C:19]([NH:21][NH:22][C:23]2[C:28]([F:29])=[C:27]([NH:30][CH2:31][C:32]3[S:33][CH:34]=[CH:35][N:36]=3)[N:26]=[C:25]([S:37][CH3:38])[N:24]=2)=[O:20])[CH2:8][N:9]([OH:12])[CH:10]=[O:11])[CH2:5][CH2:4][CH2:3][CH2:2]1参加物
4
反応物 1
生成物 1
試薬・触媒・溶媒 2
実験手順
[(2R)-2-(Cyclopentylmethyl)-3-(2-{5-fluoro-2-(methylthio)-6-[(1,3-thiazol-2-ylmethyl)amino]-4-pyrimidinyl}hydrazino)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide (0.2197 g, 0.387 mmol) was dissolved in acetic acid (8 mL) and water (2 mL). This reaction mixture was left to stir over 3 days. The volatiles were evaporated, and the resulting residue was purified by RP-HPLC to provide [(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro-2-(methylthio)-6-[(1,3-thiazol-2-ylmethyl)amino]-4-pyrimidinyl}hydrazino)-3-oxopropyl]hydroxyformamide as a beige solid (0.0878 g, 47%). LCMS: (M+H)+=484.2.
後処理
- waitThis reaction mixture was left
- customThe volatiles were evaporated
- customthe resulting residue was purified by RP-HPLC
出典と根拠
- ORDレコード
- ord-961da4b1e855425eb525364884c68be5
- 出典データセット
- uspto-grants-2011_02
- 特許番号
- US07893056B2
反応ノート
読み込み中…